These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29114905)

  • 61. The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis.
    Bouchelouche K; Nordling J; Hald T; Bouchelouche P
    J Urol; 2001 Nov; 166(5):1734-7. PubMed ID: 11586212
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
    van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities.
    Pacheco Y; Freymond N; Devouassoux G
    J Asthma; 2014 Feb; 51(1):1-17. PubMed ID: 23834429
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Montelukast in guidelines and beyond.
    Bousquet J; Demoly P; Humbert M
    Adv Ther; 2009 Jun; 26(6):575-87. PubMed ID: 19562275
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Montelukast as a treatment modality for eosinophilic gastroenteritis.
    De Maeyer N; Kochuyt AM; Van Moerkercke W; Hiele M
    Acta Gastroenterol Belg; 2011 Dec; 74(4):570-5. PubMed ID: 22319970
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Leukotriene receptor antagonists (Montelukast) in the treatment of asthma crisis: preliminary results of a double-blind placebo controlled randomized study.
    Ferreira MB; Santos AS; Pregal AL; Michelena T; Alonso E; de Sousa AV; Pereira E; Palma-Carlos AG
    Allerg Immunol (Paris); 2001 Oct; 33(8):315-8. PubMed ID: 11763721
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Eosinophilic gastroenteritis in a young girl--long term remission under Montelukast.
    Quack I; Sellin L; Buchner NJ; Theegarten D; Rump LC; Henning BF
    BMC Gastroenterol; 2005 Jul; 5():24. PubMed ID: 16026609
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria.
    Sanada S; Tanaka T; Kameyoshi Y; Hide M
    Arch Dermatol Res; 2005 Sep; 297(3):134-8. PubMed ID: 16044256
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of montelukast sodium on the duration of effusion of otitis media.
    Combs JT
    Clin Pediatr (Phila); 2004; 43(6):529-33. PubMed ID: 15248005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effects of montelukast on intradermal wheal and flare.
    Hill SL; Krouse JH
    Otolaryngol Head Neck Surg; 2003 Sep; 129(3):199-203. PubMed ID: 12958567
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Leukotriene antagonists--do they have a value?].
    Stey C
    Praxis (Bern 1994); 2000 Mar; 89(14):586-90. PubMed ID: 10815466
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oral montelukast and cetirizine for thyroid eye disease.
    Lauer SA; Silkiss RZ; McCormick SA
    Ophthalmic Plast Reconstr Surg; 2008; 24(4):257-61. PubMed ID: 18645426
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson's Disease.
    Wallin J; Svenningsson P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070609
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Double-Blind, Randomized, Crossover Study to Compare the Effectiveness of Montelukast on Atopic Dermatitis in Korean Children.
    Jeon YH; Min TK; Yang HJ; Pyun BY
    Allergy Asthma Immunol Res; 2016 Jul; 8(4):305-11. PubMed ID: 27126723
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Atopic diseases of childhood.
    Stone KD
    Curr Opin Pediatr; 2003 Oct; 15(5):495-511. PubMed ID: 14508299
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Atopic dermatitis: elements in clinical study design and analysis.
    Abrams BB
    Acta Derm Venereol Suppl (Stockh); 1989; 144():15-9. PubMed ID: 2678864
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Atopic dermatitis nomenclature variants can impede harmonization.
    Hanifin JM
    J Invest Dermatol; 2012 Feb; 132(2):472-3; author reply 473-4. PubMed ID: 21938010
    [No Abstract]   [Full Text] [Related]  

  • 78. [A new age of atopic dermatitis therapy].
    Barbarot S
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):525-527. PubMed ID: 31221476
    [No Abstract]   [Full Text] [Related]  

  • 79. Reporting of Patient Global Assessments in Atopic Dermatitis Randomized Controlled Trials.
    Grinich EE; Pawlitschek T; Simpson EL
    Dermatitis; 2020; 31(1):e7-e9. PubMed ID: 31688131
    [No Abstract]   [Full Text] [Related]  

  • 80. Leukotriene Antagonists in Dermatology.
    Bubna AK
    Indian J Dermatol; 2021; 66(5):575. PubMed ID: 35068536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.